Get started
Source

Current Drug Targets - Immune Endocrine & Metabolic Disorders

ISSNs: 1568-0088, 1875-5917
Source type: journal
Alternate name: Current drug targets. Immune, endocrine and metabolic disorders
Fully OA: No
DOAJ: No
OpenAlex ID: S118480599
Protein-Tyrosine Phosphatase 1B (PTP1B): A Novel Therapeutic Target for Type 2 Diabetes Mellitus, Obesity and Related States of Insulin Resistance
2001 · Barry J. Goldstein · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 153
Skin Photoprotection by Green Tea: Antioxidant and Immunomodulatory Effects
2003 · Santosh K. Katiyar · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 145
Dual Roles of Adiponectin / Acrp30 In Vivo as an Anti-Diabetic and Anti- Atherogenic Adipokine
2003 · Toshimasa Yamauchi, Kazuo Hara, et al. · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 141
Regulation of the Steroidogenic Acute Regulatory Protein Expression: Functional and Physiological Consequences
2005 · P. R. Manna, D. M. Stocco · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 139
Cytomegalovirus Infection in Immunocompetent and Immunocompromised Individuals - A ReviewCytomegalovirus Infection in Immunocompetent and Immunocompromised Individuals - A Review
2001 · Z. Vancikova, P. Dvorak · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 131
DI-2-Ethylhexyl Phthalate and Endocrine Disruption: A Review
2004 · Giuseppe Latini, Alberto Verrotti, et al. · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 125
Insulin Regulation of PEPCK Gene Expression: A Model for Rapid and Reversible Modulation
2005 · P. G. Quinn, D. Yeagley · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 112
Role of FXR in Regulating Bile Acid Homeostasis and Relevance for Human Diseases
2005 · G. Rizzo, B. Renga, et al. · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 111
CXCR3-binding Chemokines: Novel Multifunctional Therapeutic Targets
2005 · E. Lazzeri, P. Romagnani · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 110
PDF
Caspases as Drug Targets in Ischemic Organ Injury
2005 · S. Faubel, C. L. Edelstein · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 101
Stearoyl-CoA Desaturase-1 and the Metabolic Syndrome
2003 · Paul Cohen, James M. Ntambi, et al. · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 97
Tissue-Specific Glucocorticoid Reactivating Enzyme, 11β-Hydroxysteoid Dehydrogenase Type 1 (11β-HSD1) - A Promising Drug Target for the Treatment of Metabolic Syndrome
2003 · Hiroaki Masuzaki, Jeffrey S. Flier · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 96
Chemokine-Chemokine Receptor Network in Immune Cell Trafficking
2004 · Chang H. Kim · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 95
Activins, Myostatin and Related TGF-β Family Members as Novel Therapeutic Targets for Endocrine, Metabolic and Immune Disorders
2004 · Kunihiro Tsuchida · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 86
Myocardial Insulin Resistance and Cardiac Complications of Diabetes
2005 · E. D. Abel · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 84
Physiological Roles of Glycogen Synthase Kinase-3: Potential as a Therapeutic Target for Diabetes and Other Disorders
2003 · J. R. Woodgett · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 81
Estrogens and Colorectal Cancer
2001 · A.D. Leo, C. Messa, et al. · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 81
Biosynthetic Pathways of Plastid-Derived Organelles as Potential Drug Targets Against Parasitic Apicomplexa
2003 · F. Seeber · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 79
Unfolding the Pathophysiological Role of Bioactive Lysophospholipids
2003 · Yan Xu, Yi-jin Xiao, et al. · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 79
Amino Acid Transporter ATB0,+ as a Delivery System for Drugs and Prodrugs
2005 · M. E. Ganapathy, V. Ganapathy · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 72
Targeting the AMP-Activated Protein Kinase for the Treatment of Type 2 Diabetes
2002 · Nicolas Musi, Laurie Goodyear · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 71
Reduction of Hepatic Glucose Production as a Therapeutic Target in the Treatment of Diabetes
2005 · Chaodong Wu, David A. Okar, et al. · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 70
Effects of Endocrine Disruptors on Developmental and Reproductive Functions
2005 · Tiziana A. L.Brevini, Simona B. Zanetto, et al. · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 65
Therapeutic Potential of the Mammalian Pyruvate Dehydrogenase Kinases in the Prevention of Hyperglycaemia
2002 · M. Sugden, M. Holness · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 62
Vaccination Against Leishmania Infections
2002 · J. Mauel · Current Drug Targets - Immune Endocrine & Metabolic Disorders · 61
Works count: 169
Citation count: 5,054
H-index: 40
I10-index: 120
2yr mean citedness:
Year
Topic
Type